Cardlytics
CDLX
103 hedge funds and large institutions have $97.9M invested in Cardlytics in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 47 reducing their positions, and 29 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
0.42% less ownership
Funds ownership: 8.98% → 8.56% (-0.42%)
15% less funds holding
Funds holding: 121 → 103 (-18)
43% less capital invested
Capital invested by funds: $172M → $97.9M (-$74.2M)
45% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 47
48% less call options, than puts
Call options by funds: $636K | Put options by funds: $1.22M
59% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$4.02M |
| 2 |
GEH
General Equity Holdings
Brooklyn,
New York
|
+$3.29M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.84M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$984K |
| 5 |
Walleye Capital
New York
|
+$947K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.21M |
| 2 |
ACM
Alua Capital Management
New York
|
-$2.4M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$2.34M |
| 4 |
MFWM
Motley Fool Wealth Management
Alexandria,
Virginia
|
-$1.37M |
| 5 |
JCM
JS Capital Management
New York
|
-$1.2M |
CDLX Hedge Fund Activity: Q1 2023 in Review
103 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q1 2023, worth a combined $97.9M — down 43% from $172M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of CDLX and 12 opened new positions — a net loss of 17 holders — while 47 trimmed existing stakes and 26 added.
The largest buyer was Marshall Wace, adding an estimated $4.02M. The largest seller was Vanguard Group, cutting an estimated $3.21M.
- 103 institutional investors held Cardlytics (CDLX) as of Q1 2023, down from 121 in Q4 2022.
- Funds reported $97.9M of Cardlytics stock for Q1 2023, down 43% quarter-over-quarter.
- 12 funds opened new Cardlytics positions in Q1 2023 and 29 closed out, a net change of -17 holders.
- The largest Cardlytics buyer in Q1 2023 was Marshall Wace, an estimated $4.02M added.
- The largest Cardlytics seller in Q1 2023 was Vanguard Group, an estimated $3.21M sold.
Based on aggregated 13F filings for Q1 2023.